The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte JEFFRY WEERS, THOMAS E. TARARA,
and ANDREW CLARK
__________
Appeal 2007-0526
Application 10/141,032
Technology Center 1600
__________
Decided: April 24, 2007
__________
Before TONI R. SCHEINER, DONALD E. ADAMS, and ERIC GRIMES,
Administrative Patent Judges.
GRIMES, Administrative Patent Judge.
DECISION ON APPEAL
This is an appeal under 35 U.S.C. § 134 involving claims to methods
of administering tobramycin. The Examiner has rejected the claims as
obvious. We have jurisdiction under 35 U.S.C. § 6(b). We affirm.
BACKGROUND
Pulmonary drug delivery techniques “rely on the inhalation of a
pharmaceutical formulation by the patient so that the active drug within the
dispersion can reach the distal (alveolar) regions of the lung” (Specification 1).
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next
Last modified: September 9, 2013